Vimarsana
Biggest News Aggregation in the World

How Big Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from How Big Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In How Big Pharma Today - Breaking & Trending Today

10 Sunday Reads - The Big Picture - Vimarsana News

10 Sunday Reads - The Big Picture

Macro Perspective on the Capital Markets, Economy, Geopolitics, Technology, and Digital Media

VIRUS MANIA PART III: Perpetual "state of emergency" the new normal for America, as long as the CDC writes the script - Vimarsana News

VIRUS MANIA PART III: Perpetual "state of emergency" the new normal for America, as long as the CDC writes the script

There has never been a more primed example of virus mania in the world than what is going on right now with COVID-19. Just recently, the CDC and corporate media have pushed out the latest, [...]

VIRUS MANIA PART II: Anthony Fauci is just the latest in a long line of virus hucksters and con artists going way back in history - Vimarsana News

VIRUS MANIA PART II: Anthony Fauci is just the latest in a long line of virus hucksters and con artists going way back in history

It is true that Anthony "Fraudulent" Fauci is at the epicenter of the SARS-Coronavirus scamdemic that has cost millions of lives around the globe while padding the pockets of Big Pharma [...]

VIRUS MANIA PART I: The FRAUD of Louis Pasteur and the entirely CORRUPT history of virology - Vimarsana News

VIRUS MANIA PART I: The FRAUD of Louis Pasteur and the entirely CORRUPT history of virology

Most natural health enthusiasts know this, but the majority of Americans would find the following fact tough to digest: "The primary purpose of commercially-funded clinical research is to [...]

2022 forecast: Will biopharma's offices ever go back to 'normal'? Sanofi, Novartis and more chime in - Vimarsana News

2022 forecast: Will biopharma's offices ever go back to 'normal'? Sanofi, Novartis and more chime in

Through much of 2021, it seemed as if COVID-19 vaccines were enabling many countries to gently ease back into normalcy. Those hopes hit a rude awakening late in the year when the omicron variant emerged, and now industry leaders are forced—again—to quickly adapt.